Professor Osagie K. Obasogie’s ‘Legacies of Eugenics’ Project
By Gwyneth Shaw,
Berkeley Law
| 08. 23. 2024
In this episode, host Gwyneth Shaw talks to Professor Osagie K. Obasogie, a professor of law and bioethics and the only UC Berkeley faculty member to hold an appointment at both our law school and our School of Public Health(opens in a new tab), including the Joint Medical Program(opens in a new tab) with UC San Francisco. As a sociologist of law and medicine, Obasogie’s research combines doctrinal scholarship with empirical methods and novel theoretical approaches to understand the ways race is central to how the institutions of law and medicine operate.
He’s the author of Blinded By Sight: Seeing Race Through the Eyes of the Blind and co-editor of Beyond Bioethics: Toward a New Biopolitics, and his scholarship has been published in top law reviews as well as major medical and science journals. Obasogie is an elected member of the National Academy of Medicine and won a Guggenheim Fellowship in 2022.
Recently, he organized and wrote the opening essay for a major project published in the Los Angeles Review of Books, “Legacies of Eugenics...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...